M. Nagata et al., Apoptotic cell death in arrhythmogenic right ventricular cardiomyopathy - A comparative study with idiopathic sustained ventricular tachycardia, JPN HEART J, 41(6), 2000, pp. 733-741
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a specific heart
muscle disease of unknown etiology characterized by; fatty and fibrofatty r
eplacement of the right ventricular myocardium. It often manifests life-thr
eatened ventricular arrhythmias. Previous studies have hypothesized that my
ocyte apoptosis contributes to the myocyte cell loss and fatty change in AR
VC and may be induced by recurrent ventricular tachycardia (VT). We examine
d whether these progressive pathological changes result from apoptotic cell
death in both autopsied and biopsied right ventricular myocardium from 35
patients with ARVC by using in situ terminal deoxynucleotidyl transferase a
ssay (TUNEL) and agarose gel electrophoresis. We also studied the biopsied
myocardium from 30 patients with idiopathic sustained VT whose origin was t
he outflow tract of the right ventricle. TUNEL-positive cells indicating DN
A fragments were observed in some cardiomyocytes and fibroblasts in ARVC, b
ut the numbers of TUNEL-positive myocytes were very low in idiopathic VT. D
NA laddering was confirmed in two autopsied cases in ARVC, but not in a non
-cardiac case who died. These results suggest that at least some cardiomyoc
ytes and fibroblasts are subjected to apoptosis in ARVC, leading to the los
s of myocardium with characteristic pathological changes and subsequently p
rogressive cardiomyopathy. Furthermore, the apoptotic process may not resul
t from myocardial ischemia due to repetitive VT.